RxDoctor Payments Data

Kristen Mazur, PA

Physician Assistant · Deland, FLNPI 1427619170

Payments from drug & device makers

$235in general payments, 2019–2025

Across 12 payments — averaging $19.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Philips North America LLC$46
  • AbbVie$40
  • Cipher Pharmaceuticals US LLC$32
  • Alkermes, Inc.$26
  • Organon$25
  • Johnson & Johnson$21
  • plus $44 from 3 others

What the payments were for

  • Food & beverage$22194%
  • Education$146%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Philips North America LLC2$46
AbbVie2$40
Cipher Pharmaceuticals US LLC1$32
Alkermes, Inc.1$26
Organon2$25
Johnson & Johnson1$21
GSK1$16
Dexcom, Inc.1$14
Takeda Pharmaceuticals U.S.A., Inc.1$14

How this compares

$235 in reported general payments places this provider in the 35th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida

Medicare billing

Part B allowed, 2024
$616
Medicare patients
39
Services billed
82

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban31$32,872
OzempicSemaglutide17$24,357
JardianceEmpagliflozin19$21,193
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr33$18,705
FarxigaDapagliflozin Propanediol13$16,923
JanuviaSitagliptin Phosphate12$11,936
TrulicityDulaglutide12$11,265
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$9,897
Lantus SolostarInsulin Glargine,hum.Rec.Anlog20$2,990
Albuterol Sulfate HfaAlbuterol Sulfate78$2,058
Fluticasone-SalmeterolFluticasone Propion/Salmeterol11$1,429
Atorvastatin Calcium153$1,275
Gabapentin57$917
Ventolin HfaAlbuterol Sulfate14$773
Levothyroxine Sodium63$672

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKAnoro Ellipta, Trelegy Ellipta$16$28,60248 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in Deland

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →